Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
14.91
+0.79 (5.59%)
Oct 9, 2026, 4:00 PM EDT - Market closed
Crescent Biopharma Employees
Crescent Biopharma had 69 employees as of June 30, 2026. The number of employees increased by 36 or 109.09% compared to the same quarter last year. That makes Crescent Biopharma the 33,454th largest employer in the world and 4,397th in the United States.
Employees
69
Change
36
Growth
109.09%
Revenue / Employee
$172,217
Profits / Employee
-$2,393,101
Market Cap
638.16M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 69 | 36 | 109.09% |
| Mar 31, 2026 | 55 | 22 | 66.67% |
| Dec 31, 2025 | 44 | - | - |
| Sep 30, 2025 | 41 | - | - |
| Jun 30, 2025 | 33 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Phathom Pharmaceuticals | 371 |
| CorMedix | 191 |
| DBV Technologies | 170 |
| Prime Medicine | 146 |
| Silence Therapeutics | 88 |
| Zevra Therapeutics | 61 |
| Shattuck Labs | 40 |
| Climb Bio | 29 |
CBIO News
- 4 days ago - Crescent Biopharma Announces Grants of Inducement Awards - GlobeNewsWire
- 5 days ago - Crescent Biopharma upgraded to Buy from Neutral at H.C. Wainwright - TheFly
- 6 days ago - Crescent Biopharma announces FDA clearance of CR-002 IND application - TheFly
- 6 days ago - Crescent Biopharma Announces FDA Clearance of IND Application for CR-002, a PD-L1-targeted Topoisomerase Inhibitor ADC, for the Treatment of Solid Tumors - GlobeNewsWire
- 26 days ago - Crescent Biopharma Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 4 weeks ago - Crescent Biopharma Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 5 weeks ago - Crescent Biopharma to Present at September Investor Conferences - GlobeNewsWire
- 2 months ago - Crescent Biopharma reports Q2 EPS (74c), consensus (64c) - TheFly